Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa Capsules, 75 mg, 110 mg, and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dabigatran Etexilate Capsules
Alembic Pharma announces US FDA tentative approval for Dabigatran Etexilate capsules
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Pradaxa capsules, 75 mg,…
Alembic Pharmaceuticals announces US FDA tentative approval for Dabigatran Etexilate capsules
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Pradaxa Dabigatran…
Glenmark Pharma gets ANDA tentative approval for Dabigatran Etexilate Capsules
It is the generic version of Pradaxa Capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim